The Impact of Postnatal Systemic Steroids on the Growth of Preterm Infants: A Multicenter Cohort Study

Postnatal steroids, often used to prevent and treat bronchopulmonary dysplasia, may influence the growth of preterm infants, although data are scarce in the literature. This is a multicenter cohort study including surviving preterm infants <32 weeks at birth (n = 17,621) from the Spanish Neonatal...

Descripción completa

Detalles Bibliográficos
Autores: Zozaya, Carlos, Avila Alvarez, Alejandro, Garcia-Munoz Rodrigo, Fermin, Couce, Maria L, Arruza, Luis, Fernandez-Perez, Cristina, Castro, Abdon, Cuesta, Maria Teresa, Vacas, Beatriz, Vento, Maximo, Saenz de Pipaon, Miguel
Tipo de recurso: artículo
Fecha de publicación:2019
País:España
Institución:Servizo Galego de Saúde (SERGAS)
Repositorio:RUNA. Repositorio da Consellería de Sanidade e Sergas
OAI Identifier:oai:runa.sergas.gal:20.500.11940/15894
Acceso en línea:https://www.ncbi.nlm.nih.gov/pubmed/31717933
http://hdl.handle.net/20.500.11940/15894
Access Level:acceso abierto
Palabra clave:Gestational Age
Bronchopulmonary Dysplasia
Humans
Adrenal Cortex Hormones
Respiration
Infant
Body Size
edad gestacional
respiración
lactante
humanos
displasia broncopulmonar
hormonas de la corteza suprarrenal
tamaño corporal
CHUAC
Descripción
Sumario:Postnatal steroids, often used to prevent and treat bronchopulmonary dysplasia, may influence the growth of preterm infants, although data are scarce in the literature. This is a multicenter cohort study including surviving preterm infants <32 weeks at birth (n = 17,621) from the Spanish Neonatal Network SEN1500 database, without major congenital malformations. Linear regression models were adjusted for postnatal steroids, respiratory severity course (invasive mechanical ventilation at 28 days), progression to moderate-severe bronchopulmonary dysplasia (O2 at 36 weeks), length of stay, sex, gestational age and z-scores at birth. A subgroup analysis depending on the timing of administration, ventilation status at 28 days and moderate-severe BPD diagnosis was also performed. Overall, systemic postnatal steroids were not independently associated with poorer weight gain (0.1; 95% CI: -0.05 to 0.2 g/kg/day), linear growth (0; 95% CI: -0.03 to 0.01 cm/week) or head circumference growth (-0.01; 95% CI: -0.02 to 0 cm/week). Patients who received steroids after 28 days or who were not O2 dependent at 36 weeks after having received steroids gained more weight (0.22; 95% CI: 0.04 to 0.4 and 0.2; 95% CI: 0.004 to 0.5 g/kg/day, respectively). Globally, systemic postnatal steroids had no significant adjusted effect on postnatal growth.